1.Allard, R. A mathematical model to describe the risk of infection from sharing injection equipment. J Acquir Immune Defic Syndr 1990; 3: 1010-1016.
2.Heymann, DL, Edstrom, K. Strategies for AIDS prevention and control in sub-Saharan Africa. AIDS 1991; 5(Suppl 1):S197–S208.
3.Hoelscher, M, Riedner, G, Hemed, Y, Wagner, H-U, Korte, R, von Sonnenburg, F. Estimating the number of HIV transmissions through reused syringes and needles in the Mbeya Region, Tanzania. AIDS 1994; 8:1609–1615.
4.Aylward, B, Kane, M, McNair-Scott, R, Hu, DH. Model-based estimates of the risk of human immunodeficiency virus and hepatitis B virus transmission through unsafe injections. Int J Epidemiol 1995; 24:446–452.
5.Kane, A, Lloyd, J, Zaffran, M, Simonsen, L, Kane, M. Transmission of hepatitis B, hepatitis C, and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull WHO 1999; 77:801–807.
6.Ekwueme, DU, Weniger, GB, Chen, RT. Model-based estimates of risks of disease transmission and economic costs of seven injection devices in sub-Saharan Africa. Bull WHO 2002; 80:859–870.
7.Hauri, AJ, Armstrong, GL, Hutin, YJF. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 2004; 15:7–16.
8.Schmid, GP, Buve, A, Mugyenyi, P, et al. Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet 2004; 363:482–488.
9.Kaplan, EH, Heimer, R. A model-based estimate of HIV infectivity via needle sharing. J Acquir Immune Defic Syndr 1992; 5:1116–1118.
10.Hudgens, MG, Longini, IM Jr, Halloran, ME, et al. Estimating the transmission probability of human immunodeficiency virus in injecting drug users in Thailand. Appl Statist 2001; 50:1–14.
11.Hudgens, MG, Longini, IM Jr, Vanichsensi, S, et al. Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand. Am J Epidemiol 2002; 155:159–168.
12.Baggaley, RF, Boily, M-C, White, RG, Alary, M. Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis. AIDS 2006; 20:805–812.
13.Porco, TC, Aragon, TJ, Fernyak, SE, et al. Quantitative Risk Assessment for Needle Reuse at a Phlebotomy Center: Parameter Estimation, Scenario Evaluation, Sensitivity Analysis. May 22, 2000. San Francisco: San Francisco Department of Public Health. Available at: http://www.dph.sf.ca.us/Reports/ndlreuse.pdf. Accessed August 1, 2006.
14.Avila, C, Stetler, HC, Sepúlveda, J, et al. The epidemiology of HIV transmission among paid plasma donors, Mexico City, Mexico. AIDS 1989; 3:631–633.
15.Banerjee, K, Rodrigues, J, Israel, Z, Kulkarni, S, Thakar, M. Outbreak of HIV seropositivity among commercial plasma donors in Pune, India [letter]. Lancet 1989; 2:166.
16.Pokrovski, W, Eramova, IIU, Deulina, MO, et al. An intrahospital outbreak of HIV infection in Elista [in Russian]. Z Microbiol Epidemiol Immunobiol 1990; 4:17–23.
17.Pokrovsky, VV. Localization of nosocomial outbreak of HIV infection in southern Russia in 1988-89. In: Proceedings of the Eighth International Conference on AIDS; July 19-24, 1992; Amsterdam, The Netherlands. Abstract PoC 4138.
18.Bobkov, A, Garaev, MM, Rzhaninova, A, et al. Molecular epidemiology of HIV-1 in the former Soviet Union: analysis of env V3 sequences and their correlation with epidemiologic data. AIDS 1994; 8:619–624.
19.Sauhat, SR, Kotova, EA, Prokopenkova, SA, et al. Risk factors for HIV transmission in hospital outbreak [abstract]. In: Proceedings of the Eighth International Conference on AIDS; July 19-24, 1992; Amsterdam, The Netherlands. Abstract PoC 4288.
20.Hersh, BS, Popovici, F, Jezek, Z, et al. Risk factors for HIV infection among abandoned Romanian children. AIDS 1993; 7:1617–1624.
21.Patrascu, IV, Dumitrescu, O. The epidemic of human immunodeficiency virus infection in Romanian children. AIDS Res Hum Retroviruses 1993; 9:99–104.
22.Hassan, NF, El Ghorab, NM, Rehim, MS, et al. HIV infection in renal dialysis patients in Egypt [letter]. AIDS 1994; 8:853.
23.Pugliese, G. HIV transmission reported in dialysis center. Infect Cont Hosp Epidemiol 1995; 16:482.
24.Wu, Z, Rou, K, Detels, R. Prevalence of HIV infection among former commercial plasma donors in rural eastern China. Health Policy Plan 2001; 16:41–46.
25.Zhang, K, Gui, X, Su, B, Chen, Z, Zhang, L. High prevalence of HIV infection among women and their children in Henan Province, China [letter]. J Acquir Immune Defic Syndr 2003; 33:649–650.
26.Ministry of Health, People's Republic of China. 2005 Update on the HIV/AIDS Epidemic and Response in China. Geneva: UNAIDS; 2006.
27.Su, B, Liu, L, Wang, F, et al. HIV-1 subtype B dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China. AIDS 2003; 17:2515–2520.
28.Beach, MV. “Blood heads” and AIDS haunt China's countryside. Lancet 2001; 357:49.
29.Shan, H, Wang, J-X, Ren, F-R, et al. Blood banking in China. Lancet 2002; 360:1770–1775.
30.Visco-Comandini, U, Cappiello, G, Luizzi, G, et al. Monophyletic HIV type 1 CRF02-AG in a nosocomial outbreak in Benghazi, Libya. AIDS Res Hum Retroviruses 2002; 18:727–732.
31.Quadri, R, Yerli, S, Posfay-Barbe, K, et al. Outbreak of blood-borne viral infections in children attending a single hospital [abstract]. Hepatology 2000; 32:281A.
32.Yerly, S, Quadri, R, Negro, F, et al. Nosocomial outbreak of multiple bloodborne viral infections. J Infect Dis 2001; 184:369–372.
33.Shields, J. Patient-to-patient transmission of HIV [letter]. Lancet 1994; 343:415.
34.Gisselquist, D. Estimating HIV-1 transmission efficiency through unsafe medical injections. Int J STD AIDS 2002; 13:152–159.
35.Bell, DM. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am J Med 1997; 102(Suppl 5B):9–15.
36.Gerberding, JL. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure; final report from a longitudinal study. J Infect Dis 1994; 170:1410–1417.
37.Tokars, JI, Marcus, R, Culver, DH, et al. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposures to HIV-infected blood. Ann Intern Med 1993; 118:913–919.
38.Kaplan, EH. Needles that kill: modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. Rev Infect Dis 1989; 11:289–298.
39.Van de Perre, P, Diakhate, L, Watson-Williams, J. Prevention of blood-borne transmission of HIV. AIDS 1997; 11(Suppl B):S89–S98.
40.Cardo, DM, Culver, DH, Ciesielski, CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med 1997; 337:1485–1490.
41.Goletti, D, Weissman, D, Jackson, RW, et al. Effect of Mycobacterium tuberculosis on HIV replication. J Immunol 1996; 157:1271–1278.
42.Gray, RH, Wawer, MJ, Brookmeyer, R, et al. Probability of HIV-1 transmission per coital act in monogamous heterosexual, HIV-1 discordant couples in Rakai, Uganda. Lancet 2001;357:1149–1153.
43.Piatak, M, Saag, MS, Yang, LC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993; 259:1749–1754.
44.Richardson, BA, Mbori-Ngacha, D, Lavreys, L, et al. Comparison of human immunodeficiency virus type 1 viral loads in Kenyan women, men, and infants during primary and early infection. J Virol 2003; 77:7120–7123.
45.Gisselquist, D, Potterat, JJ, Brody, S. HIV transmission during paediatric health care in sub-Saharan Africa: risks and evidence. S Afr Med J 2004; 94:109–116.
46.Heimer, R, Abdala, N. Viability of HIV-1 in syringes: implications for interventions among injection drug users. AIDS Reader 2000; 10:410–417.
47.Grund, J-PC, Stern, LS. Residual blood in syringes: size and type of syringe are important. AIDS 1991; 5:1532–1533.
48.Hughes, RR. Post-penicillin jaundice. BMJ 1946; 2:685–688.
49.Rich, JD, Dickinson, BP, Carney, JM, Fisher, A, Heimer, R. Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection. AIDS 1998; 12:2345–2350.
50.Kanitakis, J, Escaich, S, Trepo, C, Thivolet, J. Detection of human immunodeficiency virus-DNA and RNA in the skin of HIV-infected patients using the polymerase chain reaction. J Invest Dermatol 1991; 97:91–96.
51.Blauvelt, A. The role of skin dendritic cells in the initiation of human immunodeficiency virus infection. Am J Med 1997; 102(Suppl 5B):16–20.
52.Soto-Ramirez, LE, Renjifo, B, McLane, MF, et al. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996; 271:1291–1293.
53.Essex, M, Renjifo, B, Peña-Cruz, V, et al. Different subtypes of HIV-1 and cutaneous dendritic cells: response [letter]. Science 1997; 278:787–788.
54.Evans, RJ, Spooner, ETC. A possible mode of transfer of infection by syringes used for mass inoculation. BMJ 1950; 2:185–188.
55.Hutin, Y, Hauri, A, Chiarello, L, et al. Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections. Bull WHO 2003; 81:491–500.
56.Resnick, L, Veren, K, Salahuddin, SZ, Tondreau, S, Markham, PD. Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. JAMA 1986; 255:1887–1891.
57.Lakshman, M, Nichter, M. Contamination of medicine injection paraphernalia used by registered medical practitioners in south India: an ethnographic study. Soc Sci Med 2000; 51:11–28.
58.Birungi, H, Asiimwe, D, Whyte, SR. Injection Use and Practices in Uganda (WHO/DAP/94.18). Geneva, Switzerland: World Health Organization; 1994.
59.Druce, JD, Locarnini, SA, Birch, CJ. Syringe cleaning techniques and transmission of HIV [letter]. AIDS 1995; 9:1105–1107.
60.Abdala, N, Cleghorn, AA, Carney, JM, Heimer, J. Can HIV-1-contaminated syringes be disinfected. J Acquir Immune Defic Syndr 2001; 28:487–494.
61.Van Bueren, J, Simpson, RA, Salman, H, Farrelly, HD, Cookson, BD. Inactivation of HIV-1 by chemical disinfectants: sodium hypochlorite. Epidemiol Infect 1995; 115:567–579.
62.Contoreggi, C, Jones, S, Simpson, P, Lange, WR, Meyer, WA III. Effects of varying concentrations of bleach on in vitro HIV-1 replication and the relevance to injection drug use. Intervirology 2000; 43:1–5.
63.Lakshmi, R. India's vaccines come with risk: dirty needles used for immunization can spread other diseases. Washington Post February 9,2005:A18.
64.Hu, DJ, Kane, MA, Heymann, DL. Transmission of HIV, hepatitis B virus, and other bloodborne pathogens in health settings: a review of risk factors and guidelines for prevention. Bull WHO 1991; 69:623–630.